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Summary
Background: Adherens junctions (AJs) provide structure to
epithelial tissues by connecting adjacent cells through homo-
philic E-cadherin interactions and are linked to the actin cyto-
skeleton via the intermediate binding proteins b-catenin and
a-catenin. Rather than being static structures, AJs are exten-
sively remodeled during development, allowing the cell rear-
rangements required for morphogenesis. Several ‘‘noncore’’
AJ components have been identified, which modulate AJs to
promote this plasticity but are not absolutely required for
cell-cell adhesion.
Results: We previously identified dASPP as a positive regu-
lator of dCsk (Drosophila C-terminal Src kinase). Here we
show that dRASSF8, the Drosophila RASSF8 homolog, binds
to dASPP and that this interaction is required for normal
dASPP levels. Our genetic and biochemical data suggest
that dRASSF8 acts in concert with dASPP to promote dCsk
activity. Both proteins specifically localize to AJs and are
mutually required for each other’s localization. Furthermore,
we observed abnormal E-cadherin localization in mutant pupal
retinas, correlating with aberrant cellular arrangements. Loss
of dCsk or overexpression of Src elicited similar AJ defects.
Conclusions: Because Src is known to regulate AJs in both
Drosophila and mammals, we propose that dASPP and
dRASSF8 fine tune cell-cell adhesion during development by
directing dCsk and Src activity. We show that the dASPP-
dRASSF8 interaction is conserved in humans, suggesting
that mammalian ASPP1/2 and RASSF8, which are candidate
tumor-suppressor genes, restrict the activity of the Src proto-
oncogene.
Introduction
Cell-cell contacts are essential for development and adult life of
multicellular organisms [1]. The best-characterized form of cell-
cell contact is the adherens junction (AJ), which links neigh-
boring cells via homotypic E-cadherin (E-Cad) interactions.*Correspondence: nicolas.tapon@cancer.org.uk
4These authors contributed equally to this work
5Present address: Developmental Neurobiology, MRC National Institute
for Medical Research, The Ridgeway, London NW7 1AA, UK
6Present address: Institute of Developmental Biology and Cancer, Univer-
sity of Nice Sophia-Antipolis, CNRS UMR 6543, Parc Valrose, Nice 06108,
FranceThe highly conserved intracellular domain of E-Cad binds to
b-catenin, which itself binds to a-catenin [2]. Transient interac-
tions between a-catenin and actin filaments link AJs to the
cytoskeleton, though the exact nature of this connection
remains controversial [3–5]. AJs are particularly important for
the integrity of epithelial tissues. In addition to establishing
and maintaining cell-cell adhesion [6], AJs regulate several
aspects of cellular behavior, including cytoskeletal rearrange-
ment and transcription [2]. Inappropriate disruption of cell-
cell contacts can lead to excess proliferation and is a hallmark
of the metastatic process [7, 8].
Dynamic remodeling of AJs occurs during all major morpho-
genetic events involving movement and rearrangement of
epithelial cells, including convergent extension and gastrula-
tion [9]. AJ remodeling is necessary for the generation of
epithelial structures with extremely precise patterns, such as
the hexagonal array of ommatidia in theDrosophila compound
eye [10].
SRC signaling is a major cellular pathway known to promote
AJ remodeling in development and metastasis. Cellular SRC
(c-SRC) is a member of the SRC family kinases (SFKs), which
include c-SRC, FYN, and YES. Activated c-SRC is known to
regulate AJs by several mechanisms. For example, c-SRC
can induce the ubiquitylation of E-Cad by an E3 ubiquitin ligase
called Hakai, promoting E-Cad internalization or degradation
[11–13]. In Drosophila, Src42A (one of two c-Src homologs)
genetically interacts with E-Cad (encoded by shotgun [shg]
in Drosophila), localizes to AJs, and forms a ternary complex
with E-Cad and Armadillo (Drosophila b-catenin) [14]. Further-
more, Src42A activation leads to decreased E-Cad protein
levels and concurrent stimulation of E-Cad transcription by
Armadillo and TCF, which is thought to be important for AJ
turnover during morphogenesis [15].
The C-terminal region of c-SRC and other SFKs is targeted
by C-terminal SRC kinase (CSK), which negatively regulates
c-SRC by phosphorylating a conserved tyrosine residue
(Tyr527 in avian c-SRC) [16]. Drosophila CSK (dCsk) appears
to function analogously to mammalian CSK as a negative regu-
lator of SFKs. dCsk is a negative regulator of tissue growth;
mutants die as giant pupae and imaginal discs are enlarged
as a result of increased proliferation [17–19]. These observa-
tions are seemingly at odds with studies showing that Src acti-
vation in Drosophila tissues stimulates proliferation but also
leads to considerable apoptosis [20]. A recent report attemp-
ted to reconcile this discrepancy, suggesting that lower levels
of Src activation induce proliferation and protection from
apoptosis, whereas high levels lead to apoptosis and invasive
migration [21].
We previously showed that dCsk activity is modulated by
dASPP, the Drosophila homolog of mammalian ASPP1 and
ASPP2, which physically interacts with dCsk and enhances
its capacity to phosphorylate Src42A [22]. Accordingly, dASPP
phenotypes are enhanced by reducing dCsk gene dosage and
are rescued by complete removal of Src64B, which functions
redundantly with Src42A [14, 23]. Here, we identify dRASSF8
as a new dASPP regulator. dRASSF8 is the homolog of
mammalian RASSF7/8 (Ras association domain family 7/8).
Ras association (RA) domain-containing proteins are putative
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Figure 1. Genomic Organization of the dRASSF8
Locus and dRASSF86 Characterization
(A) Diagram representing the domain structure of
dRASSF8. Conserved consensus domains are
shown between dRASSF8 (NP_651411) and its
human (NP_009142 for hRASSF8) or C. elegans
(K05B2.2) homologs. Percent amino acid identity
is indicated.
(B) Genomic organization of the CG5053/
dRASSF8 locus. The G15974 P element was
excised to generate mutants. dRASSF84 is a rein-
sertion of G15974 into the dRASSF8 50 untrans-
lated region (UTR). dRASSF82 and dRASSF86
are deletions of 0.8 and 1.4 kb, respectively.
(Ca and Cb) Third-instar larval eye imaginal disc
harboring eyFLP/FRT-generated dRASSF86
clones marked by absence of GFP in green
(Ca). Note strongly reduced and/or absent
dRASSF8 protein in red (Cb). Scale bar repre-
sents 50 mm.
(D) Reverse transcriptase-polymerase chain
reaction (RT-PCR) analysis of transcript levels in
extracts from control and mutant flies. dRASSF8
mutants are ordered left to right, corresponding
to increasing strength of phenotype. tankyrase
transcript levels appear unaffected in dRASSF8 mutants, as do dASPP transcript levels (RA and RB). actin transcript levels were assayed as a control.
(E–H) Characterization of the dRASSF86 overgrowth phenotype. dRASSF86 mutant flies (F) have enlarged wings compared to controls (E), as illustrated by
the merge (G). Quantifications of the overgrowth phenotypes are shown in (H). dRASSF8 mutants have larger wings because of an increase in cell number
but not cell size. Mutant flies are also heavier than controls. Numbers of flies or wings in (H) from left to right: 150, 180, 100, 25, 20, 20, 12, 12. In this graph and
all subsequent graphs, data are represented as mean 6 standard deviation. **p < 0.01 by Student’s t test.
(I) Rescue experiment. dRASSF8 protein levels are shown on western blot for dRASSF8ctrl (+/+), dRASSF86 (2/2), and the rescue by ubiquitous expression
of dRASSF8 under the control of the armadillo (arm) promoter.
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1970Ras effectors; they specifically bind the activated (GTP-bound)
form of Ras family GTPases, which function in numerous signal
transduction pathways regulating proliferation, apoptosis, and
differentiation. Mammalian RASSF family members 1–6 are
characterized by their domain structure, with a C-terminal
RA domain, a C1-like zinc finger, and a SARAH (Salvador-
RASSF-Hippo) domain [24]. Mammalian RASSF7–10 are atyp-
ical RASSF proteins because they contain an N-terminal RA
domain and lack a C1-like or SARAH domain. Recently, Xeno-
pus RASSF7 was shown to be required for completing mitosis
[25]. Human RASSF8 is a putative tumor-suppressor gene;
when expressed in lung cancer cells, RASSF8 inhibits
anchorage-independent growth [26]. Importantly, the molec-
ular function of RASSF8 has not been elucidated.
Two RASSF family proteins are encoded by the Drosophila
genome. dRASSF is similar to human RASSF1–6 and has
been linked to the Hippo pathway [27]. dRASSF8 is similar to
human RASSF7 and RASSF8, having an N-terminal RA domain.
Published genome-wide yeast two-hybrid data suggested that
dRASSF8 interacts with dASPP, prompting us to investigate
the relationship between these proteins. Based on our genetic
and biochemical data, we suggest that the dASPP-dRASSF8
complex regulates AJs by directing the activity of dCsk and
Src.
Results
Generation of dRASSF8 Mutants
CG5053/dRASSF8 is a conserved gene encoding a 607 amino
acid protein with an N-terminal RA domain (Figure 1A).
dRASSF8 shows significant homology to human RASSF7 and
RASSF8 within the RA domain (57% and 70% amino acid iden-
tity, respectively).
G15974 (Genexel) is a P element insertion 2 bp upstream of
the dRASSF8 transcription start site, which was impreciselyexcised to generate deletions at the dRASSF8 locus (Fig-
ure 1B). A precise excision line, dRASSF8ctrl, was obtained
to use as a control and, as expected, had no phenotype.
dRASSF86 removes the first exon and part of the second
exon (Figure 1B). An 81 bp section of the 50 untranslated region
(UTR) of the neighboring gene, tankyrase, is also deleted,
raising the possibility that dRASSF86 is a double mutant for
dRASSF8 and tankyrase. However, the level of tankyrase tran-
script was not obviously affected in dRASSF86 mutants
compared to dRASSF8ctrl flies (Figure 1D). Thus, dRASSF86
is likely to represent a ‘‘clean’’ dRASSF8 allele.
When dRASSF86 mutant clones were generated in the eye-
antennal imaginal discs (the larval precursors to the adult
structures), we observed a complete loss of dRASSF8 protein
within clones with an antibody directed against dRASSF8 (Fig-
ure 1C). Semiquantitative reverse transcriptase-polymerase
chain reaction (RT-PCR) analysis revealed that dRASSF8 tran-
script levels were reduced in all alleles generated. Interest-
ingly, the reduction in transcript observed for each allele corre-
sponded to the strength of phenotype of that allele (Figure 1D).
dRASSF8 transcript was completely absent from dRASSF86
samples, suggesting that it is a null allele (Figure 1D).
dRASSF8 Negatively Regulates Tissue Growth
dRASSF86homozygotesshowa broadwing phenotype. Mutant
wings are shorter along the proximodistal axis and broader
along the anteroposterior axis compared to dRASSF8ctrl wings
(Figures 1E–1G). In density-controlled crosses, the average
wing area of dRASSF86 homozygous flies was 5.8% larger
than dRASSF8ctrl wings. Importantly, the wing hair density of
dRASSF86 mutants was comparable to control wings, indi-
cating that dRASSF86 mutant wings are larger because they
contain more cells rather than larger cells (Figure 1H). This
suggests that proliferation is increased in dRASSF86 mutant
wings and that dRASSF8 negatively regulates the size of
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Figure 2. dRASSF8 Is Required for Normal Eye Development
(A and B) Scanning electron micrographs (SEMs) of control
and mutant eyes. Homozygous mutants for dRASSF86 (B)
have rough and enlarged eyes compared to the control,
dRASSF8ctrl (A).
(C and D) High-magnification SEMs of the indicated geno-
types showing the patterning defects elicited by loss of
dRASSF8.
(E and F) Pupal retinas at 40 hr APF (after puparium forma-
tion) stained with an anti-Armadillo antibody to visualize
cell outlines. dRASSF8 mutants (F) show defects in the
arrangement of pigment cells and sensory bristles compared
to controls (E). A double layer of interommatidial cells can be
observed in (F). Scale bars represent 20 mm.
(G and H) Pupal retinas at 27 hr APF stained with an active
caspase-3 (C3) antibody. dRASSF86 mutants (H) show
reduced developmental apoptosis compared to controls
(G). Scale bars represent 50 mm.
(Ia–Id) Active caspase-3 staining (red) of a mosaic pupal
retina at 27 hr APF (Ib). Wild-type (WT) tissue is labeled by
GFP (green), and dRASSF86 mutant tissue is GFP negative
(Ia). Binary masks defining the mutant tissue area and their
inversions defining the control tissue area were created and
applied to the caspase-3 staining, allowing the visualization
and quantification of apoptosis in control (Ic) and mutant
(Id) areas. Confocal acquisitions were processed via a
computer-based method (see Supplemental Experimental
Procedures). Scale bar represents 50 mm.
(J–L) Quantification of interommatidial cell (IOC) number in
dRASSF8ctrl and dRASSF86 ommatidia (J); quantification of
bristle cell number in dRASSF8ctrl and dRASSF86 ommatidia
(K); quantification of apoptotic index in dRASSF86 mutant
clonal tissue versus control tissue (L). ***p < 0.001 by Mann-
Whitney U test.
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1971developing tissues. Accordingly, the adult body weight of
dRASSF86 mutants is 10.5% higher than that of control flies
(Figure 1H). The overgrowth phenotype was rescued by ubiqui-
tous expression of dRASSF8 under the control of the armadillo
(arm) promoter via the GAL4/UAS system, indicating that the
observed phenotypes are specific to loss of dRASSF8 (Figures
1H and 1I).
dRASSF8 Is Required for Normal Eye Development
dRASSF86 homozygous mutants have enlarged, rough eyes
compared to controls (Figures 2A and 2B). High-magnification
scanning electron micrographs (SEMs) of dRASSF86 eyes
reveal severe patterning defects that cause a disruption of
the hexagonal ommatidial lattice and clustering of bristles (Fig-
ures 2C and 2D). The phenotype of dRASSF86 eyes was exam-
ined at the pupal stage with an anti-Arm antibody to mark cell
outlines. At 40 hr after puparium formation (APF), patterning
is largely complete [28], dRASSF8ctrl retinas show a regular
arrangement of hexagonal units (Figure 2E), the bristle cells
are evenly spaced, and each one invariably contacts three
secondary pigment cells. At 40 hr APF, dRASSF86 mutant
retinas show a range of patterning defects (Figure 2F; see
also Figure S1 available online for further details). Therefore,
dRASSF8 is likely to regulate cell-cell adhesion, which plays
a crucial role in patterning the Drosophila eye.
A striking phenotype of dRASSF86 mutant retinas is the in-
crease in the number of interommatidial cells (IOCs). In 40 hr
APF control retinas, the IOCs (secondary and tertiary pigment
cells) and bristle cells form a single layer of cells around each
ommatidium following cell rearrangements and apoptosis of
excess cells (Figure 2E). In dRASSF86 retinas, we often
observed a double layer of IOCs, indicating an excess of this
cell type (Figure 2F). Quantification (see SupplementalExperimental Procedures) revealed that dRASSF86 ommatidia
have a significant increase in IOC number (16.21 6 1.88 cells
per ommatidium) compared with dRASSF8ctrl ommatidia
(12.16 6 0.49 cells per ommatidium, p < 0.001) (Figure 2J).
There was no significant difference in the number of bristle
cells in dRASSF86 ommatidia, but the number was highly vari-
able, presumably because of the altered cell arrangement in
mutant retinas (Figure 2K).
dRASSF8 Is Required for Apoptosis of Excess
Cells in the Drosophila Eye
The increase in the number of IOCs suggests a delay in cell-
cycle exit and/or a defect in developmental apoptosis, which
removes excess IOCs from the retina between 24 hr and
40 hr APF [29]. The dRASSF86 eye phenotype is at least partly
due to reduced apoptosis, because we observed a notable
decrease in active caspase-3 staining in dRASSF86 retinas at
27 hr APF (when apoptosis is maximal) (Figure 2H) compared
to dRASSF8ctrl retinas (Figure 2G). We quantified the level of
caspase staining in 27 hr APF retinas containing dRASSF86
mutant clones (see Supplemental Experimental Procedures).
Quantification revealed that apoptosis was significantly
reduced by w20% in dRASSF86 mutant tissue compared to
control tissue (Figures 2I and 2L; p < 0.001). The reduction in
retinal apoptosis was more striking when the entire retina
was mutant for dRASSF8, possibly as a result of perdurance
of dRASSF8 protein in clones. These data suggest that at least
some of the excess IOCs in dRASSF86 mutant retinas arise
from a failure to undergo apoptosis between 24 and 40 hr
APF. We did not observe any obvious change in the levels of
apoptosis in dASPP mutant clones at 27 hr APF, suggesting
that this phenotype is specific to loss of dRASSF8 (Figures
S2A and S2B).
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Figure 3. dRASSF8 Physically Interacts with
dASPP to Modulate dCsk Activity
(A) Coimmunoprecipitation of dASPP and
dRASSF8. Drosophila Kc167 cells were cotrans-
fected with pAc5.1-dRASSF8-HA and pAC5.1-
dASPP-myc. HA, Myc, and control (GFP) immu-
noprecipitates and input (1/10) were probed
with anti-Myc (bottom) and anti-HA (top) anti-
bodies, respectively.
(B) Affinity purification of tagged versions of
RASSF8 and mass spectrometry on immunopre-
cipitated proteins. ASPP1 and ASPP2 interact
with RASSF8. Sequence coverage (in percent)
and unique peptides number are indicated (see
Supplemental Experimental Procedures). The
experiment was done in duplicate. Only proteins
identified with more than two unique peptides
and not detected in control purifications are listed.
(C) Immunoprecipitations followed by kinase
assays were used to assess the kinase activity
of a tagged form of dCsk (dCsk-myc) on a bacte-
rial Src substrate (GST-Src42AK276R). dCsk alone
and a negative control (mock immunoprecipita-
tion with GFP antibody, marked by the asterisk)
are shown (lanes 1 and 2). Input (1/5) and immuno-
precipitated protein levels are shown by western
blots. GST-Src42AK276R levels are shown after
Coomassie blue staining. dCsk kinase activity
was quantified on a phosphorimager and normal-
ized to immunoprecipitated kinase levels (see
Experimental Procedures). Fold change is indi-
cated at the top of each lane. Cotransfection of
Kc167 cells with dCsk-myc and dASPP-HA
results in an enhancement of dCsk activity
(compare lane 1 to lane 3). dRASSF8RNA interfer-
ence (RNAi) treatment abolished the dASPP-
dependent enhancement of dCsk activity (lane 4).
dRASSF8 RNAi alone has little effect on dCsk activity (lane 5). RNAi efficiencies were tested by RT-PCR (bottom row).
(D) Quantification of the effects of dRASSF8 levels on dASPP-dependent enhancement of dCsk activity. Numbers of immunoprecipitations followed by kinase
assays are indicated (n). **p < 0.01 and *p < 0.05 by Student’s t test.
(E–H)dRASSF8anddCskgenetically interact. Immunostainings withantibodies againstcleavedcaspase-3 (C3, red) and Discs large (Dlg, green) fromthird-instar
larval wing imaginal discs of the indicated genotypes are shown. Scale bar represents 50 mm.
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1972dRASSF8/RASSF8 Physically Interacts
with dASPP/ASPP1/2
Our initial interest in dRASSF8 stemmed from its interaction
with dASPP in published yeast two-hybrid genome-wide data
[30]. We confirmed the two-hybrid result by coimmunoprecipi-
tation in Drosophila Kc167 cells cotransfected with Myc-
tagged dASPP and HA-tagged dRASSF8. dASPP-Myc was de-
tected in HA immunoprecipitates, but not in control (GFP)
immunoprecipitates (Figure 3A). Furthermore, dRASSF8-HA
was detected in Myc but not control (GFP) immunoprecipitates
(Figure 3A), confirming that dRASSF8 and dASPP can indeed
associate.
In order to assess whether the dASPP-dRASSF8 association
is evolutionarily conserved, we performed an unbiased affinity
purification of hRASSF8 complexes from human cells.
Epitope-tagged hRASSF8 was tandem affinity purified from
stably transfected HEK293 cells. Liquid chromatography-
tandem mass spectrometry (LC-MS/MS) analysis of the puri-
fied complexes revealed that the major interacting partners
of hRASSF8 in HEK293 cells are ASPP1 and ASPP2, the human
homologs of dASPP (Figure 3B; Table S1). The MS results were
confirmed by coimmunoprecipitation experiments in HEK293
cells. We were able to detect both ASPP1 and ASPP2 in
RASSF8 immunoprecipitates, but not in RASSF6 immunopre-
cipitates (Figure S3). Therefore, ASPP1 and ASPP2 specifically
interact with RASSF8. These data strongly suggest thatdRASSF8 physically interacts with dASPP, that they function
in a common signaling pathway, and that this interaction is
conserved in humans.
dRASSF8 Modulates dCsk Activity in a dASPP-Dependent
Manner
We have previously demonstrated that dASPP binds to and
enhances the kinase activity of dCsk on Src42A in a dose-
dependent manner [22]. Because dRASSF8 binds to dASPP,
we hypothesized that dRASSF8 might modulate dASPP func-
tion in the Src pathway, and we used kinase assays to address
this possibility. Myc-tagged dCsk was immunoprecipitated
from Drosophila Kc167 cells, and in vitro kinase assays were
performed with GST-Src42AK267R, a kinase-dead form of
Src42A, as a substrate. As expected, the kinase activity of
dCsk was potentiated by cotransfection of dASPP (Figure 3C).
We found that dRASSF8 RNA interference (RNAi) treatment
suppressed the enhancement of dCsk kinase activity by
dASPP (Figures 3C and 3D). By itself, the dRASSF8RNAi treat-
ment has only a minor effect on dCsk activity. These results
suggest that dRASSF8 functions via dASPP to regulate dCsk
activity.
We formerly showed that reducing dCsk function in a
dASPP8 mutant background by introducing a strong hypomor-
phic allele (dCsk j1d8) elicits considerable caspase activation in
wing discs and a notched wing phenotype [22]. This is also the
dASPP
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Figure 4. dASPP and dRASSF8 Colocalize at Adherens Junctions
(Aa–Ac) dRASSF8 and dASPP colocalize and are membrane-associated
proteins. Apical sections (XY) of the wing epithelia show colocalization of
dRASSF8 (red) and dASPP (green).
(Ba–Bc) Transversal sections (XZ) of wing epithelia show apical colocaliza-
tion of dRASSF8 (red) and dASPP (green).
(C and D) Localization of known apical proteins. Atypical protein kinase C
(aPKC) is apical with respect to E-cadherin (E-Cad) (C), and Dlg is basal
with respect to E-Cad (D).
(E–H) dASPP and dRASSF8 colocalize with adherens junction (AJ) proteins
(Arm and E-Cad, G and H, respectively), but not with other apical proteins
(aPKC and Dlg, E and F, respectively).
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1973case when dCsk j1d8 is introduced into a mutant background
for dASPPd (Figures 3F and 3H), an independently generated
allele (see Figure S4 for details). In this genetic background,
we also observed notching of adult wings (68% of adults had
notched wings, n = 100). dRASSF8 and dCsk also genetically
interact, though to a weaker extent; removing one copy of
dCsk in a dRASSF86 background induces moderate levels of
ectopic apoptosis in wing discs (Figures 3E and 3G) but never
results in wing notching (0% of adult wings, n = 150). This
finding is consistent with the notion that dRASSF8 influences
dCsk activity indirectly via dASPP.
dASPP and dRASSF8 Colocalize at AJs
Though our previous study of dASPP [22] suggested that it
controls dCsk activity, the spatial aspects of this regulation
remain unclear. We therefore generated antibodies for dASPP
and dRASSF8, which were used to examine their subcellular
localization. In accordance with their physical interaction in
cultured cells, we found that dASPP and dRASSF8 colocalize
at apical cell membranes in third-instar wing discs (Figures 4Aand 4B). To examine this localization more precisely, we
looked for colocalization with known apical proteins. Atypical
protein kinase C (aPKC) was used as a marker for the
subapical domain, E-Cad and Arm were used as markers of
AJs, and Discs large (Dlg) was used as a marker of septate
junctions [31]. As expected, aPKC is apical to E-Cad (Fig-
ure 4C) and Dlg is basal to E-Cad (Figure 4D). Interestingly,
dRASSF8 colocalizes perfectly with E-Cad (Figure 4H) and,
accordingly, dASPP colocalizes with Arm (Figure 4G). In
agreement with this, dASPP is basal to aPKC (Figure 4E) and
dRASSF8 is apical with respect to Dlg (Figure 4F). These
results indicate that the dASPP-dRASSF8 complex specifi-
cally localizes to AJs in epithelial cells.
dASPP and dRASSF8 Regulate Each Other’s
Presence at AJs
Because dRASSF8 and dASPP physically interact and colocal-
ize at AJs, we asked whether they regulate each other’s local-
ization. We observed a reduction of apical dASPP staining in
dRASSF86 clones (Figures 5A and 5B) and milder reduction
of apical dRASSF8 staining in dASPPd clones (Figures 5C and
5D). These results were confirmed in eye imaginal discs (Fig-
ures 5E and 5F).
We addressed whether the effect that dRASSF8 and dASPP
have on each other’s AJ localization is due to mislocalization
and/or a reduction of protein levels. We examined dASPP
and dRASSF8 protein levels by western blot in control and
mutant wing imaginal disc extracts. dASPP protein levels are
strongly reduced in dRASSF86 mutants, whereas dRASSF8
levels are only weakly affected in dASPP mutants (Figure 5G).
Thus, dRASSF8 regulates dASPP protein levels in epithelial
cells and hence affects its accumulation at AJs. This is likely
to be via a posttranscriptional mechanism because dASPP
transcript levels are normal in dRASSF8 mutants (Figure 1D).
Such mutual stability regulation is not unusual among proteins
that are associated in a complex. Because we observed only
a minor reduction of dRASSF8 levels in dASPP mutants by
western blot, it seems unlikely that this alone can account for
the reduction of dRASSF8 observed by immunofluorescence.
Therefore, it is possible that dASPP regulates both the locali-
zation and levels of dRASSF8 protein. Together, these data
suggest that dASPP and dRASSF8 have an interdependent
relationship and regulate each other’s function in epithelia.
dASPP and dRASSF8 Regulate Cell-Cell Adhesion
in the Developing Pupal Retina
We have shown that dASPP and dRASSF8 localize to AJs and
are required for correct patterning of the retina, which promp-
ted us to examine whether E-Cad or Arm localization is
affected in mutant tissue. We chose to analyze retinas at 26–
27 hr APF. At this stage, adhesive forces between different
cell types drive the cell rearrangements necessary for estab-
lishing the lattice [10], and dASPP and dRASSF8 localize to
AJs (Figures S2C–S2E). Within dASPP and dRASSF8 mutant
clones, E-Cad staining is punctate in appearance and does
not form continuous outlines around each cell, as seen in
surrounding control tissue (Figures S5A and S5B). Accord-
ingly, we found that Arm is abnormally localized in dASPP
clones (Figure 6A). The AJ defects are especially obvious in
retinas fully mutant for dASPP or dRASSF8 (Figures 6B–6D).
The available dASPP-RNAi line strongly diminishes dASPP
(Figure S8D), and, in 26–27 hr APF retinas, AJ defects were
observed in flippase-out (flip-out) clones expressing dASPP-
RNAi under the control of the actin promoter (Figure S6A). We
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Figure 5. dASPP and dRASSF8 Regulate Each
Other’s Localization to Adherens Junctions
(Aa–Dc) Immunostainings performed on wing
imaginal discs showing the apical localization of
dRASSF8 (red) and dASPP (green) in dRASSF86
clones or dASPPd clones labeled by absence
of b-galactosidase staining (blue). XY sections
(A and C) and XZ sections (B and D) are shown.
Note the reduction of dASPP staining in
dRASSF86 clones and of dRASSF8 staining in
dASPPd clones. Scale bars in (A) and (C) repre-
sent 40 mm. Scale bars in (B) and (D) represent
10 mm.
(Ea and Eb) dASPP immunostaining (red) of eye
imaginal discs bearing dRASSF86 clones (labeled
by absence of GFP). Note the reduction of dASPP
staining in dRASSF86 clones. Scale bar repre-
sents 50 mm.
(Fa and Fb) dRASSF8 immunostaining (red) in eye
imaginal discs bearing dASPP8 clones (labeled
by absence of GFP). Note the reduction of
dRASSF8 staining in dASPP8 clones. Scale bar
represents 50 mm.
(G) Western blot of wing imaginal disc extracts.
Control, dASPPd, dASPP8, and dRASSF86
extracts were loaded onto SDS polyacrylamide
gel electrophoresis (SDS-PAGE) gels and probed
against dASPP (top), dRASSF8 (middle), and
tubulin (bottom). Molecular weights are indicated
on the left in kDa. Note that dASPP protein level is
strongly decreased in dRASSF86 wing disc
extracts, whereas dRASSF8 protein levels are
only mildly affected in dASPP mutants.
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1974did observe occasional AJ breaks in control tissue at 26–27 hr
APF; therefore, we quantified the AJ index (the percentage of
the cell membrane positive for E-Cad; see Supplemental Exper-
imental Procedures, Figure S6, and [32] for details) for control
anddASPP-RNAi-expressing cells. The AJ index of control cells
was significantly higher (80.4% 6 9.42%, n = 20) than that of
dASPP-RNAi cells (45.3%6 9.38%, n = 20, p < 0.001), confirm-
ing that loss of dASPP affects localization of E-Cad in 26–27 hr
APF retinas (Figure 6E).
Interestingly, although obvious patterning defects are
observed, the appearance of AJs is normal in dRASSF8 and
dASPP mutant retinas at 40 hr APF and does not remain frag-
mented (Figure 2F; Figures 6F and 6G). This suggests that
dRASSF8 and dASPP regulate AJs during the earlier stages
of retinal development, when cells undergo dynamic rear-
rangements, but do not maintain AJs at later stages when
patterning is complete.
Because AJs are thought to interact with the actin cytoskel-
eton, we asked whether apical actin was affected in dASPP-
deficient clones. We induced single-cell dASPP-RNAi-
expressing flip-out clones early in pupal development, and
when two dASPP-RNAi-expressing cells neighbored each
other, we commonly found breaks in AJs (Figure 7A; Fig-
ure S7A), which were associated with gaps in the apical actin
network (Figure 7A).
Taken together, these results, and the fact that dASPP regu-
lates dCsk activity, raise the possibility that dRASSF8 and
dASPP signal through dCsk and Src to regulate AJs during
retinal morphogenesis. We noted that the AJ phenotype is
more pronounced in dASPP than dRASSF8 clones, which is
in agreement with the notion that dASPP is the primary regu-
lator of dCsk in the dASPP-dRASSF8 complex (Figure 3).
Further supporting this model, we found that Arm is extremely
poorly localized in 26–27 hr APF retinas expressing dCsk-RNAi(Figures 7B and 7C). The AJ defects are more pronounced in
dCsk-RNAi retinas than in dASPP mutant retinas, which is
consistent with the fact that dCsk has a stronger loss-of-func-
tion phenotype than dASPP.
We wished to test whether Src overexpression could reca-
pitulate the effects on AJ protein localization caused by loss
of dASPP or dCsk. However, overexpressing either Src42A
or Src64B via the GMR-Gal4 driver led to complete eye abla-
tion (data not shown). This is likely the result of massive
apoptosis because high levels of Src overexpression cause
cell death in Drosophila imaginal discs [20, 23]. Therefore,
we generated single-cell flip-out clones, which were analyzed
6–8 hr after induction, with the aim of observing the early
consequences of Src overexpression before apoptosis is
induced. Expressing UAS-Src42A or UAS-Src64B in these
flip-out clones caused severe AJ defects (Figure 7D and
Figure S7B, respectively). The AJ index of control cells
(78.7% 6 6.7%, n = 12) was significantly higher than that
of Src64B-expressing cells (55.3% 6 9.3%, n = 12, p < 0.001)
(Figure S7C). It is unlikely that the effect on AJs is simply
a consequence of cell death, because we observed Src-over-
expressing cells with AJ defects that had clearly not yet begun
to delaminate. Together, these results are consistent with a
model in which the dASPP-dRASSF8 complex regulates AJs
via dCsk and Src. Localization of Dlg, a septate junction
protein, is unaffected in dASPP and dRASSF8 mutant tissue
(Figure S5C; data not shown). This suggests that the dASPP-
dRASSF8 complex specifically regulates AJs to modulate
cell-cell adhesion during retinal morphogenesis, which is
consistent with their subcellular localization.
We next asked whether dASPP or dRASSF8 localization is
AJ dependent. Expressing a-Catenin-RNAi under the control
of the patched (ptc) promoter strongly reduced a-catenin
levels (Figures S8A and S8B), showing that the RNAi line is
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Armadillo Localization during Retinal Morphogenesis
(Aa and Ab) Pupal retina at 27 hr APF stained with anti-Arm antibody to visu-
alize AJs. Arm is not properly localized in dASPP8 mutant tissue (GFP nega-
tive) compared to control tissue (GFP positive).
(B–D) Retinas at 26 hr APF stained with anti-E-Cad to visualize AJs. E-Cad
staining is punctate and fragmented indASPPd mutant retinas (C) compared
to control (dASPPd heterozygous) retinas (B). Milder AJ defects are
observed in dRASSF86 mutant retinas (D).
(E) Quantification of AJ index. The AJ index of dASPP-RNAi cells is signifi-
cantly lower than that of control cells; see Supplemental Experimental
Procedures and Figure S6 for further information. ***p < 0.001 by Student’s
t test.
(F and G) Retinas at 40 hr APF stained with anti-E-cad. At later stages of
pupal development, patterning defects are obvious, but AJs do not remain
fragmented in dASPPd mutant compared to control (dASPPd heterozygous)
retinas. In all panels, arrows indicate AJ defects. Scale bars represent 10 mm.
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1975effective. We also observed a reduction in apically localized
dASPP (Figures 7E and 7F) and dRASSF8 (Figure S8C), sug-
gesting that the localization of dASPP and dRASSF8 is depen-
dent on functional AJs.
Lastly, we explored genetic interactions between the
dASPP-dRASSF8 complex and AJs. Removing a copy of shg,
which encodes E-Cad, enhanced the dRASSF8 eye phenotype
(Figures 7G and 7H). The eye area of dRASSF8 mutants
(100% 6 6.4%, n = 5) was increased by removing a copy of
shg (115%63.6%, n = 6, p < 0.01), as was the number of omma-
tidia per eye (777 6 12, n = 5 compared to 819 6 16, n = 6, p <
0.01). Furthermore, reducing the gene dosage ofarmenhanced
the dASPP eye phenotype (Figures 7I and 7J). The eye area of
dASPP mutants (100% 6 2.2%, n = 5) was increased by
removing a copy of arm (107% 6 3.3%, n = 5, p < 0.01), as
was the number of ommatidia (820 6 16, n = 5 compared to
8446 8, n = 5, p < 0.05). Thus,dRASSF8 anddASPPgenetically
interact with AJ components, and, together, these data
support the notion that the dASPP-dRASSF8 complex regu-
lates AJs during eye development.
Discussion
dRASSF8 and N-Terminal RASSF Proteins
dRASSF8 is the sole Drosophila homolog of mammalian
RASSF7 and RASSF8, which are so-called N-terminal RASSF
proteins and the least-studied members of the RASSF family.
We have demonstrated that dRASSF8 binds to dASPP in
Drosophila cells and that RASSF8 binds to ASPP1 and
ASPP2 in human cells (Figure 3; Table S1; Figure S3), indi-
cating that we have uncovered an evolutionarily conserved
relationship between these proteins. The function of RASSF8
is currently unknown, and this study thus provides new
insights into the function of N-terminal RASSF proteins.
Future experiments will determine whether RASSF7 also
binds ASPP family proteins or whether this function is specific
to RASSF8. RASSF7 has been studied in Xenopus and was
found to associate with centrosomes and to be required for
completing mitosis [25]. In contrast, our data suggest that
dRASSF8 is not required for cell-cycle progression because
null mutants for dRASSF8 are viable. These findings are
suggestive of divergent functions for RASSF7 and RASSF8 in
vertebrates, with dRASSF8 being functionally analogous to
RASSF8 rather than RASSF7. Indeed, GFP-tagged RASSF7
localizes to the nucleus and centrosomes in Xenopus embryos
[25], whereas we never observed nuclear localization of
dRASSF8. Further studies of N-terminal RASSF proteins in
vertebrates should clarify whether RASSF7 and RASSF8
have overlapping or independent functions.
The Relationship between dASPP and dRASSF8
Our in vivo data point at a close relationship between
dRASSF8 and dASPP, which colocalize and are required for
each other’s presence at AJs in epithelial cells (Figure 4;
Figure 5). We show that dRASSF8 posttranscriptionally regu-
lates the levels of dASPP protein in epithelia. Thus, it seems
likely that binding to dRASSF8 stabilizes dASPP and prevents
its degradation, which can be observed for many protein
complexes. Overall, our data provide compelling evidence
for a functional link between dRASSF8 and dASPP, which is
likely to be conserved through to their closest mammalian
counterparts, RASSF8 and ASPP1/2.
Our data suggest that dRASSF8 has some dASPP-indepen-
dent roles. For example, dRASSF8 mutant wings are large and
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(Aa–Ad) Retina at 27 hr APF bearing single-cell
dASPP-RNAi flip-out clones (GFP positive) and
stained for actin (red) and E-Cad (blue). dASPP-
RNAi-expressing interommatidial cells (but not
cone or primary pigment cells) are marked by
asterisks in (Aa) and (Ac) for clarity. Arrows indi-
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and the corresponding gaps in apical actin.
(B and C) Retinas at 27 hr APF stained for Arm to
visualize AJs. In dCsk-RNAi-expressing retinas,
Arm is extremely poorly localized (C) compared
to control retinas (B).
(Da and Db) Retina at 27 hr APF harboring single-
cell UAS-Src42A-expressing clones (GFP
labeled) and stained for E-Cad. Arrow indicates
AJ defects. Note that not all GFP-positive cells
show AJ defects (see Figure S7 for explanation).
(Ea–Fb) dASPP localization requires AJs. Driving
a-Catenin-RNAi in wing discs using ptc-Gal4
leads to loss of apically localized dASPP, as seen
in XY (E) and XZ (F) sections. The line indicates
where the Z section was taken.
(G–J) SEMs of adult flies of the indicated geno-
types. The size of dRASSF8 mutant eyes is
enhanced by removing a copy of shg (G and H),
and the dASPP eye phenotype is enhanced by
removing a copy of arm (I and J). Scale bars in
(A)–(D) represent 10mm; scale bar in (E) represents
50 mm.
Current Biology Vol 19 No 23
1976broadened (Figure 1), whereas dASPP mutant wings are large
but of normal shape [22]. In addition, the dRASSF8 adult eye
phenotype is more marked than that of dASPP mutants.
Accordingly, we find that dRASSF8, but not dASPP, is
required for apoptosis of excess IOCs in the developing pupal
retina (Figure 2; Figure S2). It therefore appears that the
dRASSF8 eye phenotype results from both reduced apoptosis
of IOCs and cell-cell adhesion defects. The subtle differences
between the dASPP and dRASSF8 phenotypes indicate
unknown functions for dRASSF8, which are not due to its
effects on dASPP. Future efforts will be aimed at elucidating
these functions.
The dASPP-dRASSF8 Complex Regulates
the dCsk-Src Pathway
Our data are consistent with a model in which dRASSF8 binds
to and positively regulates dASPP and, in this way, promotes
dCsk activity indirectly. Our current and previous coimmuno-
precipitation experiments support this idea, showing that
dRASSF8 and dASPP associate (Figure 3) and that dASPP
and dCsk associate [22]. However, we could not detect an
interaction between dRASSF8 and dCsk (data not shown),
indicating that dRASSF8 does not directly associate with
dCsk. The proposed model is also supported by our genetic
data; the dRASSF8-dCsk genetic interaction is weaker than
the dASPP-dCsk interaction, suggesting that dASPP is the
primary regulator of dCsk (Figure 3). The weaker genetic rela-
tionship between dRASSF8 and dCsk can be explained by the
observation that some dASPP protein persists in dRASSF8
mutant tissue (Figure 5). These observations suggest that
dRASSF8 regulates dCsk via dASPP.The dASPP-dRASSF8 Complex and Adherens Junctions
Retinal morphogenesis involves dynamic changes in cell-cell
contacts to create the final ordered array of photoreceptors
and accessory cells [33]. dASPP and dRASSF8 are required
for normal E-Cad localization in 26–27 hr APF retinas (Figure 6;
Figure S5), providing an explanation for the patterning defects
in mutant eyes. We propose that the abnormal E-Cad localiza-
tion in dASPP mutant eyes results from increased Src activity
based on several lines of evidence. dASPP binds to and posi-
tively regulates dCsk, leading to Src inhibition; therefore, loss
of dASPP increases Src activity, which is known to reduce
cell-cell adhesion by promoting the internalization and degrada-
tion of E-Cad [11–15]. In agreement with this, we have shown
that loss of dCsk or overexpression of either Drosophila Src
leads to loss of AJ material in 26–27 hr APF retinas. This claim
is further supported by the fact that the dASPP eye phenotype
is suppressed by loss of Src64B [22]. Thus, the presence of
the dASPP-dRASSF8 complex at AJs may be required to locally
prevent inappropriate Src activation and dissolution of AJs.
The fact that dASPP and dRASSF8 mutants are homozy-
gous viable implies that these genes are dispensable for the
majority of morphogenetic processes occurring during devel-
opment. Therefore, the regulation of AJs by dASPP and
dRASSF8 may be restricted to the eye. However, as they are
expressed in other epithelial tissues, a closer examination of
dASPP and dRASSF8 mutants may reveal subtle defects in
other morphogenetic processes.
We suggest that dASPP and dRASSF8 are new noncore AJ
components and part of the machinery that ensures the fine
regulation of AJs by Src during development. This regulation
is crucial to provide precisely the right amount of junctional
dASPP and dRASSF8 Regulate Cell-Cell Adhesion
1977plasticity to allow cell-cell rearrangements and patterning to
take place while limiting this plasticity to maintain epithelial
coherence and prevent cell delamination. Because the interac-
tion between these proteins is conserved in mammals, this
finding is likely to be relevant to mammalian development
and to the metastatic process, which is associated with down-
regulation of E-Cad and loss of cell-cell adhesions [7, 8].
Indeed, ASPP1 knockout mice present defects in the assembly
of lymphatic vessels consistent with a potential adhesion
defect [34]. This suggests that regulation of cell-cell adhesion
may underlie the function of ASPP1/2 and RASSF8 as mamma-
lian tumor suppressors.
Experimental Procedures
For Drosophila genotypes, primer sequences, dRASSF8 and dASPP muta-
genesis, RT-PCR, dRASSF8 transgenesis, mass spectrometry, mammalian
cell culture, quantification of interommatidial cell number, apoptotic index,
and AJ index, see Supplemental Experimental Procedures.
Drosophila Stocks
dCsk j1d8 was a gift from R. Cagan. FRT42D, shgR69, and UAS-Src42A were
gifts from P. Rørth. Other stocks were from the Bloomington Drosophila
Stock Center, the Vienna Drosophila RNAi Centre, or have been published
previously by our laboratory.
Genetics and Immunohistochemistry
Weight, relative wing size, cell size, and cell number measurements were
performed as previously described [22]. Scanning electron microscopy
(SEM) was performed as previously described [27]. Pupae were staged by
collecting white prepupae and incubating at 25C for indicated times. The
Flippase/Flippase Recombination Target (FLP/FRT) system (eyFLP or
hsFLP drivers) was used to generate mosaic tissues. Larval and pupal
tissues were immunostained as previously described [22]. Primary anti-
bodies used were rabbit anti-dRASSF8 (see below), rat anti-dASPP38
[22], rabbit anti-Src64B (see below), rabbit anti-cleaved caspase-3
(Asp175) (Cell Signaling Technology), mouse anti-Discs large (Develop-
mental Studies Hybridoma Bank [DSHB]), and rabbit anti-aPKC (DSHB),
all at a concentration of 1/500; rat anti-DE-cadherin (DSHB) and rat
anti-a-catenin (DSHB) at 1/50; mouse anti-Armadillo (DSHB) at 1/10; and
mouse anti-b-galactosidase (Promega) at 1/1000. Secondary antibodies
used were rhodamine red-X donkey anti-rabbit, anti-rat, and anti-mouse,
fluorescein isothiocyanate (FITC) donkey anti-rabbit, anti-rat, and anti-
mouse (Jackson ImmunoResearch), goat anti-rat 647, and goat anti-rabbit
633 (Alexa). Phalloidin-594 (Alexa) was incubated with secondary antibodies
at 1/100. Fluorescence images were acquired with a Zeiss LSM510 confocal
microscope or LEICA SPI TCSNT confocal DMR microscope.
Drosophila Kc167 Cell Assays
dRASSF8 was amplified from EST GH01133 (Drosophila Genomics
Resource Centre) with primers dRASSF8-50 and dRASSF8-30 no stop and
cloned into the Gateway pActin5C 3xHA vector (DrosophilaGateway Vector
Collection). dASPP-RA and dCsk-RB 6xMYC have been previously
described [22]. Transfections were done with Effectene reagent (QIAGEN).
Kc167 cells were treated with dRASSF8 or DsRed RNAi for 4 days. RNAi
was synthesized with T7 RiboMAX large-scale RNA production systems
(Promega). RNAi primers (RNAif dRASSF8, RNAir dRASSF8, RNAif DsRed,
and RNAir DsRed) were designed with the GenomeRNAi online tool
(http://www.dkfz-heidelberg.de/signaling/ernai/ernai.html).
dRASSF8 transcript analysis was done on total RNA isolated with the
RNeasy mini kit (QIAGEN). RNA samples (2 mg per reaction) were treated
with RNase-free DNase (Sigma) and were reverse transcribed with cDNA
Synthesis System (Roche). The generated cDNA was used for RT-PCR
with RNAif dRASSF8, RNAir dRASSF8, RNAif dCsk, RNAir dCsk, and actin
5C primers.
Western Blotting, Immunoprecipitation, Kinase Assays,
and Antibody Generation
Cells were collected and lysed in 200 ml of lysis buffer. After clearing material
by centrifugation, samples were resolved by SDS polyacrylamide gel elec-
trophoresis (SDS-PAGE) and proteins transferred to polyvinylidene difluor-
ide (PVDF) membranes.Immunoprecipitations were done on 250 mg of protein in lysis buffer for 2
hr at 4C. IP kinase assays were performed as previously described [35]. Ten
micrograms of GST Src42AK276R [22] was added to the reactions as
a substrate. The Odyssey Infrared Imaging System (LI-COR Biosciences)
was used to normalize the amount of immunoprecipitated dCsk-RB by
western blot analysis via infrared fluorescence detection. A Molecular
Dynamics STORM 860 PhosphorImager was used for autoradiography
and quantification of the kinase assays.
Proteins were visualized by immunoblotting with mouse anti-c-Myc
(9E10): sc-40, rabbit anti-c-Myc (A-14): sc-789 (Santa Cruz Biotechnology),
rat anti-HA (3F10) (Roche), and mouse anti-GFP (Cancer Research UK
Monoclonal Antibody Service), all at 1/5000. Anti-tubulin (DSHB) was used
for normalization at 1/5000. Chemiluminescence was observed with ECL
Plus western blotting detection system (Amersham Biosciences). Rat IRDye
700DX-labeled antibody and rabbit IRDye 800-labeled antibody (Rockland)
were used for the Odyssey Infrared Imaging System.
The following antibodies were generated and affinity purified by Eurogen-
tec SA: rabbit anti-dRASSF8 (dRASSF8-08) (against a peptide correspond-
ing to the last 15 C-terminal amino acids), rabbit anti-dASPP (used for
western blotting) (against a GST-dASPPCt fusion protein [described in
[22]), and rabbit anti-Src64B (against a peptide corresponding to amino
acids 540–552).
Supplemental Data
Supplemental data include Supplemental Experimental Procedures, one
table, and eight figures and can be found online at http://www.cell.com/
current-biology/supplemental/S0960-9822(09)01847-8.
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